X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adult (2) 2
aged (2) 2
bevacizumab (2) 2
cancer (2) 2
female (2) 2
hematology, oncology and palliative medicine (2) 2
humans (2) 2
index medicus (2) 2
middle aged (2) 2
oncology (2) 2
alleles (1) 1
angiogenesis (1) 1
angiogenesis inhibitors - adverse effects (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal, humanized (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apoptosis (1) 1
autophagy (1) 1
autophagy - genetics (1) 1
bevacizumab - administration & dosage (1) 1
bevacizumab - adverse effects (1) 1
bevacizumab-associated perforation (1) 1
bevacizumab-associated toxicity (1) 1
bleeding (1) 1
blood pressure (1) 1
bowel perforation (1) 1
camptothecin - administration & dosage (1) 1
camptothecin - analogs & derivatives (1) 1
carcinoma, ovarian epithelial (1) 1
care and treatment (1) 1
cetuximab - administration & dosage (1) 1
chemotherapy, adjuvant (1) 1
clinical trials (1) 1
colorectal cancer (1) 1
colorectal carcinoma (1) 1
colorectal neoplasms - drug therapy (1) 1
confidence intervals (1) 1
endothelial growth factors (1) 1
epithelial ovarian-cancer (1) 1
fallopian-tube cancer (1) 1
fluorouracil - administration & dosage (1) 1
folfiri/bevacizumab (1) 1
gastrointestinal perforation (1) 1
genes (1) 1
genetic aspects (1) 1
genotype (1) 1
genotypes (1) 1
hypertension (1) 1
hypertension - chemically induced (1) 1
hypertension - complications (1) 1
ileus - complications (1) 1
inhibition (1) 1
intestinal perforation - chemically induced (1) 1
leucovorin - administration & dosage (1) 1
male (1) 1
measurement (1) 1
medicine, preventive (1) 1
metastases (1) 1
metastasis (1) 1
metastatic colorectal-cancer (1) 1
neoplasm metastasis (1) 1
neoplasms, glandular and epithelial - drug therapy (1) 1
obstetrics & gynecology (1) 1
obstetrics and gynecology (1) 1
ovarian cancer (1) 1
ovarian neoplasms - drug therapy (1) 1
patients (1) 1
phagocytosis (1) 1
phase-ii consortia (1) 1
plus bevacizumab (1) 1
plus chemotherapy (1) 1
polymorphism (1) 1
polymorphism, single nucleotide - genetics (1) 1
preventive health services (1) 1
primary peritoneal (1) 1
progression (1) 1
protein-tyrosine kinases - genetics (1) 1
proteinuria (1) 1
recurrent ovarian (1) 1
senescence (1) 1
single nucleotide polymorphisms (1) 1
single-nucleotide polymorphism (1) 1
stress (1) 1
therapy (1) 1
thromboembolism (1) 1
toxicity (1) 1
trial (1) 1
two phase (1) 1
vascular endothelial growth factor (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Cancer, ISSN 0959-8049, 2017, Volume 77, pp. 13 - 20
Abstract Purpose The most frequent bevacizumab-related side-effects are hypertension, proteinuria, bleeding and thromboembolism. To date, there is no biomarker... 
Hematology, Oncology and Palliative Medicine | Hypertension | Single-nucleotide polymorphism | Bevacizumab-associated toxicity | FOLFIRI/bevacizumab | Autophagy | Colorectal cancer | APOPTOSIS | INHIBITION | ONCOLOGY | SENESCENCE | STRESS | PLUS BEVACIZUMAB | PROGRESSION | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Bevacizumab - administration & dosage | Bevacizumab - adverse effects | Humans | Middle Aged | Genotype | Male | Neoplasm Metastasis | Protein-Tyrosine Kinases - genetics | Fluorouracil - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colorectal Neoplasms - drug therapy | Hypertension - chemically induced | Polymorphism, Single Nucleotide - genetics | Adult | Camptothecin - administration & dosage | Cetuximab - administration & dosage | Female | Aged | Autophagy - genetics | Chemotherapy, Adjuvant | Camptothecin - analogs & derivatives | Genetic aspects | Metastasis | Single nucleotide polymorphisms | Thromboembolism | Vascular endothelial growth factor | Medicine, Preventive | Preventive health services | Measurement | Endothelial growth factors | Blood pressure | Toxicity | Genes | Colorectal carcinoma | Clinical trials | Patients | Two phase | Bleeding | Bevacizumab | Metastases | Confidence intervals | Angiogenesis | Alleles | Phagocytosis | Genotypes | Polymorphism | Proteinuria | Cancer | Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.